Asian Spectator

Men's Weekly

.

MedAlliance Receives Fourth FDA Breakthrough Device Designatio...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
NYON, Switzerland, March 4, 2021 /PRNewswire-AsiaNet/ -- MedAlliance, the first drug-eluting balloon (DEB) company in the world to receive US Food and Drug Administration (FDA) Breakthrough Device Designation Status for a sirolimus DEB, has now been awarded breakthrough status for SELUTION SLR(TM), its ...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Diplomasi mendadak Prabowo jadi mediator AS - Iran: Langkah berani atau cari panggung?

(DPN)● Rencana Prabowo mediasi Amerika-Iran memicu keraguan.● Prabowo seakan ingin berperan seimbang untuk bertahan dari tekanan dari luar dan dalam negeri .● Tanpa daya tawar, media...

Masa depan padel: Antara gengsi atau turun kelas agar tren ini langgeng

● Padel sedang menjadi tren teratas aktivitas kaum urban sejak beberapa tahun terakhir.● Padel sudah menjelma sebagai validasi gaya hidup modern pemainnya.● Tren main padel akan sege...

The world’s largest climate finance deal was built to flounder: why funding fails to reach the front-line

Adopted in December 2015, the Paris Agreement commits countries to keeping global temperature rise below 2°C above pre-industrial levels. All 195 signatories set their own plans to meet this share...